Carbohydrate recognition by Clostridium difficile toxin A

被引：112

作者：

Greco, A

Ho, JGS

Lin, SJ

Palcic, MM

Rupnik, M

Ng, KKS ^{[1
]}

机构：

[1] Univ Calgary, Alberta Ingenu Ctr Carbohydrate Sci, Calgary, AB T2N 1N4, Canada

[2] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada

[3] Inst Publ Hlth, Maribor, Slovenia

[4] Univ Alberta, Dept Chem, Edmonton, AB, Canada

[5] Carlsberg Lab, Valby, Denmark

来源：

NATURE STRUCTURAL & MOLECULAR BIOLOGY | 2006年 / 13卷 / 05期

基金：

美国国家科学基金会; 加拿大健康研究院; 美国国家卫生研究院;

关键词：

D O I：

10.1038/nsmb1084

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Clostridium difficile TcdA is a large toxin that binds carbohydrates on intestinal epithelial cells. A 2-angstrom resolution cocrystal structure reveals two molecules of alpha-Gal-(1,3)-beta-Gal-(1,4)-beta-GlcNAcO(CH2)(8)CO2CH3 binding in an extended conformation to TcdA. Residues forming key contacts with the trisaccharides are conserved in all seven putative binding sites in TcdA, suggesting a mode of multivalent binding that may be exploited for the rational design of novel therapeutics.

引用

收藏

页码：460 / 461

页数：2

相关论文

共 16 条

[1] The new Clostridium difficile -: What does it mean? [J].

Bartlett, JG ;

Perl, TM .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2503-2505

[2] Toxin binding of tolevamer, a polyanionic drug that protects against antibiotic-associated diarrhea [J].

Braunlin, W ;

Xu, QW ;

Hook, P ;

Fitzpatrick, R ;

Klinger, JD ;

Burrier, R ;

Kurtz, CB .

BIOPHYSICAL JOURNAL, 2004, 87 (01) :534-539

[3] A receptor decoy inhibits the enterotoxic effects of Clostridium difficile toxin a in rat ileum [J].

Castagliuolo, I ;

LaMont, JT ;

Qiu, BS ;

Nikulasson, ST ;

Pothoulakis, C .

GASTROENTEROLOGY, 1996, 111 (02) :433-438

[4] Solution structure of two xenoantigens:: αGal-LacNAc and αGal-Lewis X [J].

Corzana, F ;

Bettler, E ;

du Penhout, CH ;

Tyrtysh, TV ;

Bovin, NV ;

Imberty, A .

GLYCOBIOLOGY, 2002, 12 (04) :241-250

[5] OLIGOSACCHARIDE SEQUENCES ATTACHED TO AN INERT SUPPORT (SYNSORB) AS POTENTIAL THERAPY FOR ANTIBIOTIC-ASSOCIATED DIARRHEA AND PSEUDOMEMBRANOUS COLITIS [J].

HEERZE, LD ;

KELM, MA ;

TALBOT, JA ;

ARMSTRONG, GD .

JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (06) :1291-1296

[6] Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A [J].

Ho, JGS ;

Greco, A ;

Rupnik, M ;

Ng, KKS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (51) :18373-18378

[7] Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C-difficile toxins [J].

Kelly, CP ;

Pothoulakis, C ;

Vavva, F ;

Castagliuolo, I ;

Bostwick, EF ;

OKeane, JC ;

Keates, S ;

LaMont, JT .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) :373-379

[8] GT160-246, a toxin binding polymer for treatment of Clostridium difficile colitis [J].

Kurtz, CB ;

Cannon, EP ;

Brezzani, A ;

Pitruzzello, M ;

Dinardo, C ;

Rinard, E ;

Acheson, DWK ;

Fitzpatrick, R ;

Kelly, P ;

Shackett, K ;

Papoulis, AT ;

Goddard, PJ ;

Barker, RH ;

Palace, GP ;

Klinger, JD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) :2340-2347

[9] Modification of surface histidine residues abolishes the cytotoxic activity of Clostridium difficile toxin A [J].

Roberts, AK ;

Shone, CC .

TOXICON, 2001, 39 (2-3) :325-333

[10] Revised nomenclature of Clostridium difficile toxins and associated genes [J].

Rupnik, M ;

Dupuy, B ;

Fairweather, NF ;

Gerding, DN ;

Johnson, S ;

Just, I ;

Lyerly, DM ;

Popoff, MR ;

Rood, JI ;

Sonenshein, AL ;

Thelestam, M ;

Wren, BW ;

Wilkins, TD ;

von Eichel-Streiber, C .

JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 54 (02) :113-117